NCT03331367View on ClinicalTrials.gov

Investigating and Characterizing the Immune Response to Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 14, 2017

Primary Completion Date

February 25, 2020

Study Completion Date

February 25, 2020

Conditions
Prostate Cancer
Interventions
PROCEDURE

Blood draw

Patients in all four study arms will provide a blood sample to evaluate the immune response to prostate cancer treatment.

PROCEDURE

Urine sample

Patients in all four study arms will provide a urine sample to evaluate the immune response to prostate cancer treatment.

Trial Locations (1)

11501

NYU Winthrop Hospital, Mineola

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03331367 - Investigating and Characterizing the Immune Response to Prostate Cancer | Biotech Hunter | Biotech Hunter